Prudential Financial’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,963
| Closed | -$289K | – | 2729 |
|
|
2023
Q1 | $289K | Buy |
+8,963
| New | +$289K | ﹤0.01% | 2274 |
|
|
2022
Q3 | – | Sell |
-52,084
| Closed | -$720K | – | 2737 |
|
|
2022
Q2 | $720K | Sell |
52,084
-83,670
| -62% | -$1.16M | ﹤0.01% | 1951 |
|
|
2022
Q1 | $2.65M | Buy |
135,754
+52,674
| +63% | +$1.03M | ﹤0.01% | 1339 |
|
|
2021
Q4 | $1.41M | Sell |
83,080
-795
| -0.9% | -$13.5K | ﹤0.01% | 1711 |
|
|
2021
Q3 | $2.34M | Buy |
83,875
+210
| +0.3% | +$5.85K | ﹤0.01% | 1374 |
|
|
2021
Q2 | $2.48M | Buy |
83,665
+280
| +0.3% | +$8.3K | ﹤0.01% | 1372 |
|
|
2021
Q1 | $2.33M | Buy |
83,385
+25,026
| +43% | +$700K | ﹤0.01% | 1381 |
|
|
2020
Q4 | $1.65M | Sell |
58,359
-2,656
| -4% | -$75.3K | ﹤0.01% | 1500 |
|
|
2020
Q3 | $1.53M | Sell |
61,015
-31,594
| -34% | -$794K | ﹤0.01% | 1449 |
|
|
2020
Q2 | $2.26M | Buy |
92,609
+39,105
| +73% | +$955K | ﹤0.01% | 1280 |
|
|
2020
Q1 | $792K | Buy |
+53,504
| New | +$792K | ﹤0.01% | 1771 |
|